Pfizer Inc

AAA

Pfizer shares experienced a healthy 7.71% gain today as the company announced a patent victory on its biggest selling drug. This stock is technically interesting because it gapped up toward the combined resistance of the October highs and the 200 DMA. These levels have prevented the bulls from pushing the price higher on several previous occasions, and we believe that this may be the case again.



PFE_121905.jpg

You May Also Like

Related Analysis
  1. Chart Advisor

    ChartAdvisor for January 30 2015

  2. Chart Advisor

    Use These Two ETFs To Profit From A Reversal In Gold

  3. Chart Advisor

    Trade Strong U.S. Small Caps with this ETF

  4. Stock Analysis

    Faceboook (FB) Revenue Surges on Mobile Ads - Stocks in the News

  5. Stock Analysis

    Zacks Rank Buys: Infinera (INFN) & PolyCom (PLCM) - Video Blog

Trading Center